Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs13097028
rs13097028
0.800 GeneticVariation GWASCAT Identification of a melanoma susceptibility locus and somatic mutation in TET2. 24980573

2014

dbSNP: rs13097028
rs13097028
0.800 GeneticVariation GWASDB Identification of a melanoma susceptibility locus and somatic mutation in TET2. 24980573

2014

dbSNP: rs4911414
rs4911414
0.710 GeneticVariation GWASDB Genome-wide association study identifies three new melanoma susceptibility loci. 21983787

2011

dbSNP: rs4911414
rs4911414
0.710 GeneticVariation BEFREE Except for rs1015363, none of the 12 tagging SNPs, genotyped to cover 239.9 kb region with polymorphisms linked to rs4911414 and rs1015362, were associated with melanoma. 22628150

2013

dbSNP: rs11263498
rs11263498
0.700 GeneticVariation GWASDB Genome-wide association study identifies three new melanoma susceptibility loci. 21983787

2011

dbSNP: rs1341866
rs1341866
0.700 GeneticVariation GWASDB A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q. 21706340

2012

dbSNP: rs1485993
rs1485993
0.700 GeneticVariation GWASDB Genome-wide association study identifies three new melanoma susceptibility loci. 21983787

2011

dbSNP: rs228437
rs228437
G 0.700 GeneticVariation GWASDB Genome-wide association study identifies three new melanoma susceptibility loci. 21983787

2011

dbSNP: rs4785752
rs4785752
0.700 GeneticVariation GWASDB Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 21926416

2011

dbSNP: rs498136
rs498136
A 0.700 GeneticVariation GWASCAT Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma. 28212542

2017

dbSNP: rs62389423
rs62389423
A 0.700 GeneticVariation GWASCAT Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma. 28212542

2017

dbSNP: rs7033503
rs7033503
0.700 GeneticVariation GWASDB Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 21926416

2011

dbSNP: rs721970
rs721970
0.700 GeneticVariation GWASDB Common sequence variants on 20q11.22 confer melanoma susceptibility. 18488026

2008

dbSNP: rs36115365
rs36115365
0.020 GeneticVariation BEFREE Herein, we investigated the modifying capacities of rs36115365-C on PC and melanoma in a cohort of 283 p16-Leiden carriers including 29 diagnosed with PC, 171 diagnosed with melanoma, 21 diagnosed with both PC and melanoma and 62 with neither PC nor melanoma. 31203567

2019

dbSNP: rs36115365
rs36115365
0.020 GeneticVariation BEFREE Of these, rs36115365-C associated with increased pancreatic and testicular but decreased lung cancer and melanoma risk, and exhibited preferred protein-binding and enhanced regulatory activity. 28447668

2017

dbSNP: rs1015362
rs1015362
0.010 GeneticVariation BEFREE Except for rs1015363, none of the 12 tagging SNPs, genotyped to cover 239.9 kb region with polymorphisms linked to rs4911414 and rs1015362, were associated with melanoma. 22628150

2013

dbSNP: rs1015363
rs1015363
0.010 GeneticVariation BEFREE Except for rs1015363, none of the 12 tagging SNPs, genotyped to cover 239.9 kb region with polymorphisms linked to rs4911414 and rs1015362, were associated with melanoma. 22628150

2013

dbSNP: rs10816595
rs10816595
0.010 GeneticVariation BEFREE Individuals having melanoma in a visibly UV-damaged site were more likely to carry MC1R rs75570604 (odds ratio [OR] 2.5), 9q31.2 rs10816595 (OR 2.5), and MTAP rs869329 (OR 1.4); these same alleles were more common in MPM patients diagnosed ≤40 years. 31794051

2019

dbSNP: rs12029406
rs12029406
0.010 GeneticVariation BEFREE In the melanoma dataset, two pancreatic cancer susceptibility variants were associated: NR5A2 (rs12029406; OR, 1.39; 95% CI, 1.01-1.92; P = 0.04) and CLPTM1L-TERT (rs401681; OR, 1.16; 95% CI, 1.01-1.34; P = 0.04). 24642353

2014

dbSNP: rs12512631
rs12512631
0.010 GeneticVariation BEFREE We found association between SNP rs12512631, located 3'downstream of GC, and risk of CM that seems to fit a dominant model (OR 1.63 95%CI 1.23-2.17 p-value 7×10(-4)). 23544077

2013

dbSNP: rs2127675
rs2127675
0.010 GeneticVariation BEFREE Two SNPs (rs1351383 and rs2127675) were associated with melanoma risk in the GenoMEL data set (P = 0.013 and 0.004, respectively), but failed in validation using the Australian data set. 23360169

2013

dbSNP: rs5759167
rs5759167
0.010 GeneticVariation BEFREE Among the probands, a significantly increased frequency of leukemia was found in the carriers of SNP rs2736098 (5p15, P = .03) and melanoma in the carriers of either SNP rs1512268 (8p21, P = .006) or SNP rs5759167 (22q13, P = .02). 21820706

2011

dbSNP: rs6673928
rs6673928
0.010 GeneticVariation BEFREE We identified highly significant associations with better melanoma OS for rs6673928, impacting IL19 expression (HR, 0.56; 95% CI, 0.41-0.77; P = 0.0002) and rs6695772, controlling the expression of BATF3 (HR, 1.64; 95% CI, 1.19-2.24; P = 0.0019). 26733611

2016

dbSNP: rs6695772
rs6695772
0.010 GeneticVariation BEFREE We identified highly significant associations with better melanoma OS for rs6673928, impacting IL19 expression (HR, 0.56; 95% CI, 0.41-0.77; P = 0.0002) and rs6695772, controlling the expression of BATF3 (HR, 1.64; 95% CI, 1.19-2.24; P = 0.0019). 26733611

2016

dbSNP: rs7335046
rs7335046
0.010 GeneticVariation BEFREE We further evaluated the associations of these two novel SNPs (rs12210050 and rs7335046) with squamous cell carcinoma (SCC) risk as well as melanoma risk. 21700618

2011